Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors
Keywords: ACh releasers; AChE inhibitors; Brain acetylcholine concentrations; BuChE; M1 M3 Receptor agonists; TAK 147; acetylcholinesterase inhibitors; alzheimer s disease; alzheimer s disease treatment; amiridine; anti AChE Activity; anti amyloid; anti inflammatory agents; anti oxidants; cholineric enhancement therapy; cortical cholinergic neurotransmission; crystal structure; donepezil hydrochloride; donepezil hydrocloride; eptastigmine; estrogen replacement therapy; galanin receptor antagonist; galanthamine; hepatotxic liability; huperzine A; metrifonate; molecular modeling; n alkyl analogs; nicotinic agonists; physostigmine; receptor dependent docking; rivastigmine; velnacrine
Document Type: Review Article
Publication date: 2000-03-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.